You are here: vision-research.eu » News » Newsdetails:

Johns Hopkins helps

Johns Hopkins helps lead discovery on efficacy and safety of 3 drugs for treating diabetic macular edema

A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs -- Eylea, Avastin and Lucentis -- used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.